Lotta Vrang

3.0k citations

78 papers · 2.3k · h-index 26

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Infectious Diseases 53
- HIV/AIDS drug development and treatment 53
- HIV/AIDS Research and Interventions 11
Virology 40
- HIV Research and Treatment 40

Co-authors: Bertil Samuelsson (29 shared papers)B. Öberg (14 shared papers)Bo Öberg (14 shared papers)Anders Hallberg (22 shared papers)Elizabeth Hamelink (12 shared papers)U. Helena Danielson (10 shared papers)Åsa Rosenquist (18 shared papers)Torsten Unge (13 shared papers)
Journals: Journal of Medicinal Chemistry (12 papers)Bioorganic & Medicinal Chemistry (9 papers)Antimicrobial Agents and Chemotherapy (8 papers)Antiviral chemistry & chemotherapy (8 papers)Antiviral Research (7 papers)
Partner nations: Sweden Belgium United States

In The Last Decade

Lotta Vrang

76 papers receiving 2.2k citations

Peers

Countries citing papers authored by Lotta Vrang

Since Specialization

Citations

This map shows the geographic impact of Lotta Vrang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotta Vrang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotta Vrang more than expected).

Fields of papers citing papers by Lotta Vrang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lotta Vrang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotta Vrang. The network helps show where Lotta Vrang may publish in the future.

Co-authors

The 25 scholars most cited alongside Lotta Vrang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lotta Vrang Line = papers co-authored together Lotta Vrang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435 Antimicrobial Agents and Chemotherapy ·Oliver Lenz, Thierry Verbinnen, Tse‐I Lin, Leen Vijgen, Maxwell D. Cummings, Jimmy Lindberg, Jan Martin Berke, Pascale Dehertogh, Els Fransen, Annick Scholliers, Katrien Vermeiren, Tania Ivens, Pierre Raboisson, Michael Edlund, Susan Storm, Lotta Vrang, Herman de Kock, Gregory Fanning, Kenneth Simmen	2010	178
2	HIV-1-Specific Reverse Transcriptase Inhibitors Show Differential Activity against HIV-1 Mutant Strains Containing Different Amino Acid Substitutions in the Reverse Transcriptase Virology ·Jan Balzarini, Anna Karlsson, María‐Jesús Pérez‐Pérez, Lotta Vrang, Johan Walbers, Hong Zhang, Bo Öberg, Anne–Mieke Vandamme, Marı́a-José Camarasa, Erik De Clercq	1993	147
3	In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor Antimicrobial Agents and Chemotherapy ·Tse‐I Lin, Oliver Lenz, Gregory Fanning, Thierry Verbinnen, Frédéric Delouvroy, Annick Scholliers, Katrien Vermeiren, Åsa Rosenquist, Michael Edlund, Bertil Samuelsson, Lotta Vrang, Herman de Kock, Piet Wigerinck, Pierre Raboisson, Kenneth Simmen	2009	142
4	Phenethylthiazolylthiourea (PETT) Compounds as a New Class of HIV-1 Reverse Transcriptase Inhibitors. 2. Synthesis and Further Structure−Activity Relationship Studies of PETT Analogs Journal of Medicinal Chemistry ·Amanda Cantrell, Per Engelhardt, Marita Högberg, S. Richard Jaskunas, Nils Gunnar Johansson, Christopher L. Jordan, Jussi Kangasmetsä, M. D. KINNICK, Peter Lind, J. M. JUN. MORIN, Mark A. Muesing, Rolf Noréen, Bo Öberg, Paul Pranc, Christer Sahlberg, Robert J. Ternansky, Robert T. Vasileff, Lotta Vrang, Sarah J. West, Hong Zhang	1996	104
5	Urea−PETT Compounds as a New Class of HIV-1 Reverse Transcriptase Inhibitors. 3. Synthesis and Further Structure−Activity Relationship Studies of PETT Analogues Journal of Medicinal Chemistry ·Marita Högberg, Christer Sahlberg, Per Engelhardt, Rolf Noréen, Jussi Kangasmetsä, Nils Gunnar Johansson, Bo Öberg, Lotta Vrang, Hong Zhang, Britt-Louise Sahlberg, Torsten Unge, Seved Lövgren, K. Fridborg, Kristina Bäckbro	1999	79
6	Inhibition of the reverse transcriptase from HIV by 3′-azido-3′-deoxythymidine triphosphate and its threo analogue Antiviral Research ·Lotta Vrang, Hervé Bazin, Gérald S. Remaud, Jyoti Chattopadhyaya, Bo Öberg	1987	78
7	Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors. Proceedings of the National Academy of Sciences ·Jan Balzarini, Anna Karlsson, Anne–Mieke Vandamme, María‐Jesús Pérez‐Pérez, Haodong Zhang, Lotta Vrang, B. Öberg, Kristina Bäckbro, Torsten Unge, Ana San‐Félix	1993	75
8	Induced‐Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target Angewandte Chemie International Edition ·Maxwell D. Cummings, Jimmy Lindberg, Tse‐I Lin, Herman de Kock, Oliver Lenz, Elisabet Lilja, Sara Felländer, Vera Baraznenok, Susanne Nyström, Magnus Nilsson, Lotta Vrang, Michael Edlund, Åsa Rosenquist, Bertil Samuelsson, Pierre Raboisson, Kenneth Simmen	2010	71
9	PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase Antimicrobial Agents and Chemotherapy ·Lotta Vrang, B. Öberg	1986	70
10	Prevention of simian immunodeficiency virus, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005 AIDS ·D Böttiger, Nils‐Gunnar Johansson, Bengt Samuelsson, Hong Zhang, Per Putkonen, Lotta Vrang, Bo Öberg	1997	69
11	Design and Synthesis of Plasmepsin I and Plasmepsin II Inhibitors with Activity in Plasmodium falciparum-Infected Cultured Human Erythrocytes Journal of Medicinal Chemistry ·Daniel Nöteberg, Elizabeth Hamelink, Johan Hultén, Mats Wahlgren, Lotta Vrang, Bertil Samuelsson, Anders Hallberg	2003	66
12	Design and Fast Synthesis of C-Terminal Duplicated PotentC₂-Symmetric P1/P1‘-Modified HIV-1 Protease Inhibitors Journal of Medicinal Chemistry ·Mathias Alterman, Hans O. Andersson, Neeraj Garg, Göran Ahlsén, Seved Lövgren, Björn Classon, U. Helena Danielson, Ingmar Kvarnström, Lotta Vrang, Torsten Unge, Bertil Samuelsson, Anders Hallberg	1999	63
13	An analysis of the inhibition of replication of HOV and MULV by some 3′-blocked pyrimidine analogs Biochemical Pharmacology ·Hervé Bazin, Jyoti Chattopadhyaya, R. Datema, Ann-Christin Ericson, Gustav Gilljam, Nils Gunnar Johansson, Jutta Hansen, Rie Koshida, Karin Moelling, Bo Öberg, Gérald S. Remaud, Göran Stening, Lotta Vrang, Britta Wahrén, Jin Cheng Wu	1989	61
14	Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet Antimicrobial Agents and Chemotherapy ·Rie Koshida, Lotta Vrang, Gustav Gilljam, Johan Harmenberg, B. Öberg, Britta Wahrén	1989	51
15	High-Speed Optimization of Inhibitors of the Malarial Proteases Plasmepsin I and II Journal of Combinatorial Chemistry ·Daniel Nöteberg, Wesley Schaal, Elizabeth Hamelink, Lotta Vrang, Mats Larhed	2003	49
16	Human immunodeficiency virus type 1 proteinase resistance to symmetric cyclic urea inhibitor analogs Antimicrobial Agents and Chemotherapy ·U. NILLROTH, Lotta Vrang, Per-Olof Markgren, Johan Hultén, A. HALLBERG, U. Helena Danielson	1997	43
17	Inhibition of human immunodeficiency virus type 1 wild-type and mutant reverse transcriptases by the phenyl ethyl thiazolyl thiourea derivatives trovirdine and MSC-127 Antiviral Research ·Hong Zhang, Lotta Vrang, Kristina Bäckbro, Peter Lind, Christer Sahlberg, Torsten Unge, Bo Öberg	1995	37
18	Characterization of a Set of HIV-1 Protease Inhibitors Using Binding Kinetics Data from a Biosensor-Based Screen SLAS DISCOVERY ·Markku Hämäläinen, Per-Olof Markgren, Wesley Schaal, Anders Karlén, Björn Classon, Lotta Vrang, Bertil Samuelsson, Anders Hallberg, U. Helena Danielson	2000	37
19	Design and Synthesis of Potent Inhibitors of the Malaria Aspartyl Proteases Plasmepsin I and II. Use of Solid-Phase Synthesis to Explore Novel Statine Motifs Journal of Medicinal Chemistry ·Per-Ola Johansson, Yantao Chen, Anna Karin Belfrage, Michael J. Blackman, Ingemar Kvarnström, Katarina Jansson, Lotta Vrang, Elizabeth Hamelink, Anders Hallberg, Åsa Rosenquist, Bertil Samuelsson	2004	36
20	Improved Structure−Activity Relationship Analysis of HIV-1 Protease Inhibitors Using Interaction Kinetic Data Journal of Medicinal Chemistry ·Cynthia F. Shuman, Lotta Vrang, U. Helena Danielson	2004	34

About Lotta Vrang

Lotta Vrang is a scholar working on Infectious Diseases, Virology, Molecular Biology, Organic Chemistry and Epidemiology, having authored 78 papers that have together received 2.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (53 papers), HIV Research and Treatment (40 papers), HIV/AIDS Research and Interventions (11 papers), Hepatitis C virus research (11 papers), Click Chemistry and Applications (10 papers), Computational Drug Discovery Methods (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and Biochemical and Molecular Research (7 papers). The work is most often cited by research in Virology (795 citations), Infectious Diseases (1.2k citations), Hepatology (416 citations), Organic Chemistry (667 citations) and Computational Theory and Mathematics (251 citations). Lotta Vrang has collaborated with scholars based in Sweden, Belgium and United States. Frequent co-authors include Bertil Samuelsson, B. Öberg, Bo Öberg, Anders Hallberg, Elizabeth Hamelink, U. Helena Danielson, Åsa Rosenquist, Torsten Unge, Jyoti Chattopadhyaya and Hong Zhang. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Antimicrobial Agents and Chemotherapy, Antiviral chemistry & chemotherapy and Antiviral Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Lotta Vrang

Impact in

Papers in i

In The Last Decade

Lotta Vrang

Peers

Countries citing papers authored by Lotta Vrang

Fields of papers citing papers by Lotta Vrang

All Works

About Lotta Vrang

Explore authors with similar magnitude of impact

Papers in